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Background. Knowledge on the effects of volatile anaesthetics on left ventricular (LV) dia-
stolic function in humans in vivo is limited. We tested the hypothesis that sevoflurane, desflur-
ane, and isoflurane do not impair LV diastolic function in young healthy humans.
Methods. Sixty otherwise healthy subjects (aged 18–48 yr) undergoing minor procedures under
general anaesthesia were studied. After randomization for the anaesthetic, transthoracic echocar-
diographic examinations were performed at baseline and under anaesthesia with 1 minimum alveo-
lar concentration (MAC) of the volatile anaesthetics during spontaneous breathing and
intermittent positive pressure ventilation (IPPV). Peak early (E0) and late (A0) diastolic velocities of
the mitral annulus were studied as the main echocardiographic indicators of diastolic function.
Results. During anaesthesia with 1 MAC under spontaneous breathing, E0 increased with desflur-
ane (P,0.001), was not significantly different with isoflurane (P¼0.030), and decreased with sevo-
flurane (P¼0.006). During IPPV, E0 was similar to baseline with desflurane (P¼0.550), insignificantly
decreased with isoflurane (P¼0.029), and decreased with the sevoflurane group (P,0.001). In con-
trast, A0 was similarly reduced in all groups during spontaneous breathing without further changes
during IPPV. Haemodynamic changes were comparable in all study groups.
Conclusions. The findings of this in vivo study indicate that desflurane and isoflurane, and most
likely sevoflurane, have no relevant direct negative effect on early diastolic relaxation in young
healthy humans. In contrast, all three volatile anaesthetics appear to impair late diastolic LV filling
during atrial contraction.
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Volatile anaesthetics induce complex cardiovascular effects
and alter calcium homeostasis.1 2 However, there are con-
flicting results regarding their effects on diastolic function
in animals, healthy humans, and patients. Whereas some
animal studies found direct impairment of diastolic myocar-
dial relaxation and ventricular filling by volatile anaes-
thetics,3–7 others found indirect negative effects on
diastolic function caused by depression of systolic left ven-
tricular (LV) function in canine models.8–11 Two studies in
patients with coronary artery disease (CAD) found impair-
ment of diastolic relaxation by isoflurane, desflurane,
sevoflurane, and halothane,12 13 whereas another study in
patients with concentric LV hypertrophy found no
additional impairment of diastolic relaxation with isoflur-
ane.14 Our own group found an impairment of systolic but
not diastolic function with sevoflurane in young healthy
subjects15 and in patients with pre-existing diastolic dys-
function,16 and with halothane in young healthy subjects.15
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Taken together, the influence of currently used volatile
anaesthetics on diastolic function is unclear, and volatile
anaesthetics might affect cardiac function differently.
Pre-existing cardiac diseases and differences in cardiac
loading conditions might have led to these conflicting
results in the assessment of the effects of volatile anaes-
thetics on diastolic function. Therefore, the aim of this study
was to evaluate for the first time the effect of the currently
used volatile anaesthetics, sevoflurane, desflurane, and iso-
flurane on diastolic function in healthy young subjects in
vivo under standardized and controlled loading and haemo-
dynamic conditions. On the basis of our previous findings,
we hypothesized that none of these volatile anaesthetics
impairs LV diastolic function in healthy young subjects.
Methods
Patients
After receiving approval by the local ethics committee
(Ethikkommission beider Basel, Basel, Switzerland) and
obtaining written informed consent, 61 patients under-
going minor surgical procedures under general anaesthesia
were enrolled (Fig. 1). Exclusion criteria were any history
or signs of cardiac, pulmonary, or systemic disease, any
medication with cardiovascular effects or side-effects, age
,18 or .50 yr, and BMI .30 kg m22. A computer-
generated random list was used to assign patients to
sevoflurane, desflurane, or isoflurane anaesthesia after per-
forming the baseline transthoracic echocardiography
(TTE). No premedication was given. After arrival in the
preoperative area, i.v. access was established, and Ringer’s
lactate was administered to replace the fluid deficit caused
by overnight fasting. The deficit per hour of fasting was
calculated as follows: 4 ml kg21 h21 for the first 10 kg of
body weight, 2 ml kg21 h21 for the second 10 kg, and
1 ml kg21 h21 for every additional kilogram. Fifty per
cent of the deficit was replaced before the start of the
study and a total of 66% until the end of the study. To
minimize nausea and vomiting potentially caused by
induction of anaesthesia, tropisetrone 4 mg (Navobanw,
Novartis Pharma, Basel, Switzerland) was given to each
patient as soon as i.v. access was established. Two-lead
electrocardiography and pulse oximetry were monitored
continuously, and arterial pressure was measured non-
invasively every 3 min (PCMS Workstation 90308-15-03,
SpaceLab Inc., Redmond, WA, USA). Simultaneously, bis-
pectral index (BISTM; Aspect 1000TM, Aspect Medical
Systems Inc., Natick, MA, USA; Software Version 1.01)
was monitored continuously. Upon induction of anaesthe-
sia, end-tidal concentrations of carbon dioxide (PE0CO2) and
volatile anaesthetic were measured continuously at the tip
of the laryngeal mask (Capnomac Ultima, Datex Ohmeda,
Helsinki, Finland). Body temperature was measured con-
tinuously and maintained above 368C. Hypotension,
defined as a decrease of .30% from baseline value in
mean arterial pressure, was treated with i.v. boluses of
phenylephrine 25–50 mg. Hypertension, defined as an
increase of .30% from baseline value in mean arterial
pressure, was treated with i.v. boluses of nitroglyerine
25–50 mg. To minimize influence on echocardiographic
measurements, the study was continued no earlier than
5 min after administration of any vasoactive medication.
Tachycardia or bradycardia was not treated, but the study
was continued only when heart rate recovered to values
between 50 and 90 beats min21.
The baseline TTE was performed in the awake and unpre-
medicated patient in a partial left lateral position. The same
position was used during all further measurements. After
completion of the baseline TTE, anaesthesia was induced by
i.v. infusion of remifentanil (Ultivaw, GlaxoSmithKline,
London, UK) delivered by a target-controlled infusion system
(Orchestra# Base Primera, Fresenius Vial, Brezins, France)
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Fig 1 CONSORT diagram showing randomization, allocation, and analysis for each study group. BL, baseline.
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beginning at a calculated end-organ concentration of
1.5 ng ml21 and increased to 2.0 ng ml21. One hundred per
cent oxygen was delivered by a facemask. Afterwards, induc-
tion was completed by inhalation of sevoflurane (Sevoranew,
Abbott International Ltd, Abbott Park, IL, USA), desflurane
(Supranew, Baxter, Deerfield, IL, USA), or isoflurane
(Foranew, Abbott International Ltd). No other narcotics,
opioids, or neuromuscular blocking agents were used. After
placement of a laryngeal mask, the inspiratory oxygen con-
centration was adjusted to 40%, the remifentanil infusion was
stopped, and the administration of volatile anaesthetics was
reduced to an end-tidal concentration corresponding to 1
minimum alveolar concentration (MAC). The MAC value
was age-adjusted according to the formula published by
Eger.17 As soon as remifentanil end-organ concentration in
the patient reached,0.1 ng ml21 (as calculated by the target-
controlled infusion system), and anaesthetic and haemo-
dynamic steady-state conditions were reached, a second TTE
was performed under spontaneous breathing (step I). After
completion of data acquisition, intermittent positive pressure
ventilation (IPPV) via the laryngeal mask was started to
achieve normoventilation (PE0CO2 4.5–5.0 kPa). Tidal volumes
were adjusted to 7–8 ml kg21. The concentration of the vola-
tile anaesthetic was kept at 1.0 MAC. During haemodynamic
steady-state conditions, a third TTE (step II) was performed,
completing the study. Subsequently, each patient underwent
scheduled surgery and anaesthesia, which was not influenced
by the study protocol.
Echocardiography
All echocardiograms were obtained with a SonosTM 5500
ultrasonographic system and a 1.8–2.1/3.6–4.1 MHz S4
probe (Philips Medical Systems, Best, the Netherlands)
according to current guidelines.18–20 All echocardiographic
data were digitally stored for subsequent off-line analysis. In
the same patient, one examiner performed all TTE examin-
ations. Standard LV short-axis and two- and four-chamber
views were obtained by the parasternal and apical views for
TTE. For recordings of pulsed-wave tissue Doppler imaging,
the sample volume was placed at the septal and lateral sides
of the mitral annulus, and the presettings of SonosTM 5000
for tissue Doppler imaging were used (Software Version
D.1). For the pulsed-wave Doppler recordings of the mitral
inflow, the sample volume was positioned between the tips
of the open mitral leaflets using optimal alignment with
transmitral blood flow. For recordings of isovolumic relax-
ation time (IVRT), the beam was slightly moved towards the
LV outflow tract to obtain recordings of both LV in- and
outflow signals. The following variables were measured:
end-diastolic and end-systolic areas (EDA and ESA, respect-
ively); peak early and late diastolic (E0 and A0, respectively)
and peak systolic (S0) velocities of the mitral annulus prede-
fined as the average of septal and lateral mitral annulus
measurements obtained by tissue Doppler imaging (Fig. 2);
peak early and late transmitral filling velocities (E and A,
respectively); and IVRT. E0 and A0 were predefined as the
main echocardiographic indicators of diastolic function, and
an E0 velocity of ,8.5 cm s21 was defined as echocardio-
graphic evidence of diastolic dysfunction.21–23 The follow-
ing parameters were calculated from these data: fractional
area change, FAC¼[(EDA2ESA)/EDA]100, E/A ratio,
and E/E0 ratio. All variables were measured at end-expiration
over three preferably consecutive cardiac cycles and aver-
aged by an experienced physician-echocardiographer
blinded to all other study data. To determine intra- and inter-
observer variabilities, a random sample of 25% of EDA,
ESA, transmitral filling velocities, IVRT, and the tissue
Doppler recordings was submitted twice to a first investi-
gator and once to a second investigator. The variabilities
then were calculated as the mean absolute difference
between both readings divided by their mean and expressed
as percentages and their 95% confidence intervals (CIs).
Statistical analysis
The sample size calculation was based on our previous
study,15 estimating that a size of 20 patients per group
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Fig 2 Recordings of pulsed-wave tissue Doppler imaging. The sample volume was placed at the septal (as indicated on left-hand side) and lateral sides
of the mitral annulus. The tissue Doppler signal reflects the movements of the mitral annulus and shows two diastolic (E0 and A0) and a systolic peak
(S0). E0 reflects early filling phase, whereas A0 is related to atrial contraction. LA, left atrium; LV, left ventricle.
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would allow to detect a difference in E0 of 15% in the
intra- and inter-group comparisons (a¼0.05 in post hoc
test, b¼0.8).
Continuous variables are presented as means (SD) and
dichotomous variables as values (%). The Kolmogorov–
Smirnov statistics showed a normal distribution for all
continuous echocardiographic and patient characteristic
data in each group. Baseline parameters were compared by
x2 test or one-way analysis of variance (ANOVA) where
appropriate. A general linear model for repeated measure-
ments was used to test the null hypothesis of lack of
differences between the study groups and within the study
groups. Only if the model gave global evidence for rejec-
tion of the null hypothesis at a P-value of ,0.05, the data
were further analysed by ANOVA for repeated measurements
followed by Bonferroni’s post hoc test for differences of
the data during steps I and II compared with the baseline
in each study group (within-group differences; a P-value
of ,0.025 was considered significant). Similarly, data
were further analysed for differences between the study
groups by one-way ANOVA and Bonferroni’s post hoc test
(inter-group differences; a P-value of ,0.025 was con-
sidered significant). All statistical analyses were performed
using SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
Results
One subject had an E0 ,8.5 cm s21 and an E/A ratio ,1
in the baseline TTE, suggesting LV diastolic dysfunc-
tion21–23 and was excluded from the further study, leaving
60 subjects (20 in each group). All groups had similar
patient characteristics except that the desflurane group was
slightly younger (Table 1).
The study was performed in all subjects without compli-
cations occurring during or after the study. One subject in
the desflurane group and one subject in the sevoflurane
group did not reach stable haemodynamic conditions
during IPPV because 1 MAC of the volatile anaesthetic
provided insufficient depth of anaesthesia for performing
mechanical ventilation. Accordingly, step II could not be
performed in these two subjects.
Baseline haemodynamic and echocardiographic par-
ameters were similar in all groups (Table 2).
Effects of volatile anaesthetics during spontaneous
breathing (step I) and IPPV (step II)
Haemodynamics, BIS, and PE0CO2 changed similarly in all
groups (Table 2). Phenylephrine but no other vasoactive
medication was administered during the study to three sub-
jects in the sevoflurane group (100–300 mg), to two sub-
jects in the desflurane group (25–500 mg), and to no
subjects in the isoflurane group (P¼0.189; x2 test).
During step I, E0 significantly increased compared with
baseline in the desflurane group (P,0.001), was not sig-
nificantly different in the isoflurane group (P¼0.030), and
decreased in the sevoflurane group (P¼0.006). During step
II, E0 was similar to baseline in the desflurane group
(P¼0.550), insignificantly decreased in the isoflurane
group (P¼0.029), and decreased in the sevoflurane group
(P,0.001). During both steps I and II, E0 was similar in
the isoflurane and sevoflurane groups (P¼0.300 and 0.131,
respectively), but significantly higher in the desflurane
group (all P0.003) (Fig. 3A). The E0 values of all sub-
jects and groups were within normal range at baseline and
during step I, and only one subject of the sevoflurane
group had an E0 value of ,8.5 cm s21, indicating diastolic
dysfunction21–23 during step II. The changes in E and
IVRT went in parallel to E0 (Table 2).
Late diastolic velocity A0 was similarly decreased in all
groups during step I, compared with baseline (all
P0.015). This reduction in late diastolic velocity was
further pronounced during step II (Fig. 3B) with an
additional small difference between the isoflurane and des-
flurane groups (P¼0.006). The changes in A developed in
parallel to A0.
The effects of sevoflurane, desflurane, and isoflurane on
EDA and E/E0 were similar, and the E/E0 ratio was below
10 in all subjects. Accordingly, there was no evidence for
differences in loading conditions or for elevated filling
pressures. Further, the effects of volatile anaesthetics on
E/A, FAC, and S0 did not differ (Table 2).
Intra- and inter-observer variabilities for the different
echocardiographic parameters are given in Table 3.
Discussion
The present study used diastolic tissue Doppler echocardio-
graphic parameters to investigate the effects of 1 MAC of
sevoflurane, desflurane, and isoflurane on LV diastolic
function in young healthy subjects with normal diastolic
and systolic LV function. E0 reflects mitral annular motion
during the rapid early filling phase. This parameter is
related to the rate of myocardial relaxation and correlates
with t,22 the time constant of the decrease in LV isovolu-
metric pressure; A0 is the annular velocity occurring during
the late filling phase, which is related to active atrial con-
traction and, therefore, can be used as a marker for global
systolic atrial function.22 24 A0 correlates well with atrial
ejection fraction, ejection force, and kinetic energy.24–26
Table 1 Subject characteristics. Values are expressed as numbers (%), mean
(range) or mean (SD). P-values were calculated by x2 test or one-way ANOVA
Sevoflurane
(n520)
Desflurane
(n520)
Isoflurane
(n520)
P-value
Female gender 7 (35) 8 (40) 5 (25) 0.592
Age (yr) 32 (18–48) 27 (19–46) 34 (20–48) 0.034
Weight (kg) 73 (15) 69 (10) 72 (11) 0.424
Height (cm) 176 (11) 174 (9) 174 (9) 0.781
Haemoglobin (g litre21) 148 (14) 146 (12) 146 (20) 0.926
Creatinine (mmol litre21) 69 (12) 67 (12) 70 (18) 0.867
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Table 2 Haemodynamics and echocardiographic parameters at baseline and during steps I and II. Values are expressed as mean (SD). P,0.025 by one-way ANOVA followed by Bonferroni’s post hoc test for differences
in the data during steps I and II compared with the baseline*, for differences between sevoflurane vs desflurane§, sevoflurane vs isoflurane†, and desflurane vs isoflurane‡. IPPV, intermittent positive pressure ventilation;
AP, arterial pressure; HR, heart rate; BIS, bispectral index; PE0CO2, end-tidal carbon dioxide partial pressure; N/A, not available. For abbreviations of echocardiographic parameters, see text
Baseline Spontaneous breathing (step I) IPPV (step II) Within-group
difference
P-value
Inter-group
difference
P-valueSevoflurane Desflurane Isoflurane Sevoflurane Desflurane Isoflurane Sevoflurane Desflurane Isoflurane
Mean AP (mm Hg) 80 (7) 79 (8) 85 (10) 64 (5)*,† 67 (7) * 71 (7) *,† 66 (5)* 67 (7)* 71 (8)* ,0.001 0.016
HR (beats min21) 65 (9) 63 (13) 59 (8) 66 (8) 69 (11) 67 (10)* 72 (9)* 75 (13)* 73 (13)* 0.001 0.761
BIS 97 (2) 97 (1) 96 (3) 34 (7) 35 (9) 36 (9) 33 (5) 34 (9) 37 (7) 0.001 0.569
PE0CO2 (kPa) N/A N/A N/A 6.7 (0.7) 7.0 (0.9) 6.7 (0.7) 4.7 (0.1) 4.7 (0.2) 4.7 (0.1) ,0.001 0.192
E0 (cm s21) 14.0 (2.6) 14.5 (1.7) 13.7 (2.5) 13.2 (2.3)*,§ 17.1 (2.3)*,§,‡ 14.6 (2.1)‡ 11.4 (2.0)*,§ 14.8 (2.0)§,‡ 12.5 (2.0)‡ ,0.001 ,0.001
A0 (cm s21) 8.3 (1.3) 7.2 (1.9) 8.0 (1.1) 6.3 (1.6)* 5.7 (1.6)* 6.7 (1.5)* 5.2 (1.8)* 4.0 (1.2)*,‡ 5.6 (1.4)*,‡ ,0.001 0.004
E (cm s21) 87 (16) 86 (13) 79 (15) 79 (17)*,§ 102 (19)*,§,‡ 85 (16)*,‡ 65 (14)*,§ 78 (14)*§,‡, 63 (11)*,‡ ,0.001 0.003
A (cm s21) 50 (10) 50 (13) 47 (9) 41 (7)* 41 (10)* 42 (9)* 38 (9)* 38 (12) * 40 (12)* ,0.001 1.000
E/A 1.8 (0.5) 1.8 (0.6) 1.7 (0.4) 2.0 (0.6)* 2.5 (1.1)* 2.1 (0.6)* 1.8 (0.7) 2.3 (0.9)* 1.7 (0.5) ,0.001 0.044
E/E0 6.3 (1.0) 6.0 (1.0) 5.8 (0.9) 6.0 (1.1) 6.0 (1.0) 5.8 (1.1) 5.7 (1.4) 5.3 (0.9) 5.1 (0.9) ,0.001 0.390
IVRT (ms) 72 (13) 66 (14) 72 (16) 63 (12)*,§ 47 (11)*,§,‡ 58 (12)*,‡ 73 (13)§ 52 (10)*,§,‡ 67 (15)‡ ,0.001 ,0.001
EDA (cm2) 18.0 (3.1) 18.4 (3.2) 20.1 (3.1) 17.0 (2.4) 18.8 (3.4) 19.2 (2.9) 16.3 (3.1)* 17.5 (3.5)* 17.4 (2.4)* ,0.001 0.149
FAC (%) 58 (4) 54 (4) 56 (6) 54 (6)* 55 (5) 55 (5) 52 (5)* 52 (5) 55 (6) 0.001 0.504
S0 (cm s21) 10.0 (1.2) 9.4 (1.1) 9.3 (1.1) 8.7 (1.5) 9.8 (1.5) 9.5 (1.4) 9.0 (2.7) 8.6 (1.4) 9.2 (1.4) 0.038 0.935
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limits. In contrast to the variable effects of the volatile
anaesthetics on early LV relaxation, we found evidence
that each of the volatile anaesthetics impaired global atrial
function as apparent by decreases in A0 during spontaneous
ventilation and IPPV. Impairment of systolic atrial function
potentially impairs late diastolic LV function (Fig. 3B).
Comparison of our findings with previous reports is com-
plicated by the fact that we investigated young and healthy
humans unlike most former studies, which investigated
patients with cardiac disease. We found that desflurane
improved E0, which is in contrast to previous in vitro and
animal studies that found negative3–7 or neutral effects8–11
of all clinically used volatile anaesthetics on diastolic func-
tion. In addition, a human in vivo study found that desflur-
ane caused impaired diastolic relaxation in subjects with
CAD.12 Also, our finding of maintained E0 during isoflur-
ane anaesthesia is in contrast to impaired early diastolic
function in subjects with CAD.13 The slightly decreased E0
during sevoflurane anaesthesia is in agreement with a pre-
vious study in subjects with CAD12 and similar to our pre-
vious study in young healthy subjects,15 although the use of
TTE at baseline vs transoesophageal echocardiography
during mechanical ventilation in that previous study prohib-
ited strong conclusions. Differences in the patients investi-
gated, in the techniques used for the assessment of diastolic
function, and the fact that subjects in previous studies were
mechanically ventilated could have contributed to the con-
flicting findings. It is important to note that despite some
impairment of E0 during mechanical ventilation in the iso-
flurane and sevoflurane groups, these changes were clini-
cally irrelevant, as only one subject from the sevoflurane
group showed diastolic dysfunction (i.e. E0 ,8.5 cm s21)
and only with mechanical ventilation.
In contrast, late diastolic peak velocity of the mitral
annulus A0—and also late transmitral filling velocity A—simi-
larly decreased with all three volatile anaesthetics. Decreases
in A0 and A suggest that volatile anaesthetics impair atrial sys-
tolic function causing potential impairment of late LV
filling.24 26 27 Missing values for FAC or ejection fraction of
the left atrium preclude stronger conclusions. Nevertheless,
our finding is in agreement with previous animal studies
showing impaired atrial contractility with volatile anaes-
thetics28 29 and a human study showing a small reduction in
late transmitral flow velocity induced by isoflurane and
halothane.13 A conflicting finding was reported by another
human study that found no relevant impairment of atrial func-
tion by sevoflurane and desflurane in CAD patients.12 Again,
differences in the study settings and investigative techniques
may have contributed to this conflicting finding.
Differences in the echocardiographic parameters of
early diastolic function between spontaneous ventilation
and IPPV, despite unchanged administration of volatile
anaesthetics, call for critical attention. One potential con-
founding factor is the change in PaCO2, but additional
factors should also be considered. A known limitation of
all echocardiographic indicators of diastolic function is
that they are influenced by cardiovascular factors other
than diastole, most notably loading conditions and systolic
functions of the ventricle and the atrium.30 All of these
factors are directly influenced by the volatile anaesthetics
themselves,31 and addition of IPPV induces further
marked changes despite the absence of muscle relaxation.
Despite these confounding factors, the present study pro-
vides valid information because the effects of the three
volatile anaesthetics on haemodynamics, atrial and ventri-
cular systolic function, PE0CO2, and depth of anaesthesia did
not differ. Loading conditions, as assessed by E/E0 and
EDA, were similar between all three volatile anaesthetics,
and E/E0 remained unchanged during all study steps. As
tidal volumes applied during mechanical ventilation were
weight-adjusted, it can be inferred that positive intrathor-
acic pressures were comparable in all groups.
Our findings of differential effects by volatile anaesthetics
on early diastolic function are in agreement with a canine
model of heart failure showing that desflurane better pre-
serves diastolic function compared with sevoflurane.11
Sympathoadrenergic effects of desflurane and isoflurane
could have resulted in better diastolic performance com-
pared with sevoflurane. However, we did not find differ-
ences in arterial pressure and heart rate between the study
groups, which questions distinct differences in sympathetic
stimulation. It remains questionable whether these slight
differences in E0 reflect differential effects of the three vola-
tile anaesthetics on diastolic function or rather slightly
differential effects on confounding factors in both
the present and the former studies.11 Moreover, the fact that
E0, an established echocardiographic indicator of diastolic
relaxation,20 was within the normal range at all study steps
in the desflurane and isoflurane groups strongly indicates
that these volatile anaesthetics have no direct effect on early
diastolic function, that is, relaxation. In addition, the fact
that E0 was within the normal range in 39/40 study steps in
the sevoflurane group suggests that sevoflurane might not
have a clinically relevant direct effect on early diastolic
function in healthy individuals. However, atrial systolic
function—and, therefore, most probably late diastolic
filling—was similarly impaired by all volatile anaesthetics
independent of mechanical ventilation. This effect may
become clinically relevant in patients with pre-existing dias-
tolic dysfunction, for example, patients who depend on
atrial contraction during LV filling.
A limitation of our study is that we did not apply invasive
methods for evaluation of haemodynamics, loading, ventri-
cular stiffness, atrial filling pressures, and diastolic function.
However, although the echocardiographic methods used in
our study for evaluation of in vivo heart function have limit-
ations, these methods represent current state-of-art tech-
niques for the non-invasive evaluation of haemodynamics,
and LV systolic and diastolic function in humans.18–20 It
has been demonstrated that there is a good correlation
between echocardiographic parameters and invasively eval-
uated parameters, and that the echocardiographic parameters
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are useful in the clinical setting.32 In addition, the findings
assessed by tissue Doppler imaging and conventional
Doppler measurement were similar. Another limitation is
that the effects of the three volatile anaesthetics could not
be studied during spontaneous respiration and normocapnia,
because volatile anaesthesia in spontaneously breathing
patients always induces hypercapnia. It seems reasonable
that similar degrees of hypercapnia induced by the three
anaesthetics resulted in similar confounding effects on the
cardiovascular system. However, because volatile anaesthe-
sia is used most frequently with assisted or mechanical ven-
tilation, the measurements were repeated during step II, for
example, normalized PE0CO2 during IPPV, but unchanged
dosage of the volatile anaesthetics. The influence of PaCO2
on diastolic function still has to be determined by further
studies. In a canine model, high or low PaCO2 did not influ-
ence myocardial contractility and LV end-diastolic pressure,
but altered peripheral systemic vascular resistance,33 provid-
ing some evidence for no direct influence on diastolic func-
tion. A further limitation is the fixed, not random, order of
the study steps I and II. However, because of the physical
properties of the anaesthetics and the continuous monitoring
of the end-tidal concentration of them, a relevant accumu-
lation of the drugs in the cardiac tissue seems unlikely.
Finally, the study protocol did not include a dose–response
evaluation, because such evaluations frequently resulted in
hypotension in a previous study when the inhalation anaes-
thetic was increased to .1 MAC, requiring administration
of vasoconstrictors or even premature termination of the
study.15 Owing to safety concerns and because adminis-
tration of vasoconstrictors may confound the results, we
abstained from doing dose–response investigations in the
present study.
In summary, using tissue Doppler parameters of diastolic
function, we found that desflurane and isoflurane, and most
likely sevoflurane, have no clinically relevant negative effect
on early diastolic relaxation in young subjects without
cardiovascular disease. In contrast, volatile anaesthetics
appear to decrease global atrial function, thereby potentially
impairing late diastolic LV filling. The findings of this study
cannot be directly transferred to patients with pre-existing
diastolic dysfunction. Therefore, further studies investigating
the effects of volatile anaesthetics in this patient population
under controlled conditions are warranted.
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